This product is for research use only, not for human use. We do not sell to patients.
| Size | Price | Stock |
|---|---|---|
| 50mg | $400 | To Be Confirmed |
| 100mg | $600 | To Be Confirmed |
| 250mg | $1150 | To Be Confirmed |
| 500mg | $1850 | To Be Confirmed |
: Cat #: V29078 CAS #: 854601-70-0 Purity ≥ 99%
Description: Naloxegol (formerly NKTR-118; AZ-13337019; PEGylated naloxol; Movantik; Moventig) is a peripherally-active/selective μ-opioid antagonist approved in 2014 for the treatment of opioid-induced constipation. It was approved in 2014 by FDA to treat constipation caused by opiate pain medications in adults with chronic pain that is not caused by cancer. Structurally, naloxegol is a pegylated analog of α-naloxol.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
| Molecular Weight (MW) | 651.78 |
|---|---|
| Molecular Formula | C₃₄H₅₃NO₁₁ |
| CAS No. | 854601-70-0 |
| Synonyms | AZ13337019; NKTR118; NKTR-118; AZ-13337019; PEGylated naloxol; Movantik |
| Solvent volume to be added | Mass (the weight of a compound) | |||
|---|---|---|---|---|
| Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
| 1mM | 1.5343 mL | 7.6713 mL | 15.3426 mL | 30.6852 mL |
| 5mM | 0.3069 mL | 1.5343 mL | 3.0685 mL | 6.1370 mL |
| 10mM | 0.1534 mL | 0.7671 mL | 1.5343 mL | 3.0685 mL |
| 20mM | 0.0767 mL | 0.3836 mL | 0.7671 mL | 1.5343 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.